About Bright Uro
Bright Uro is a company based in Aliso Viejo (United States) founded in 2021 by Derek Herrera.. Bright Uro has raised $94.99 million across 8 funding rounds from investors including NIH, Laborie Medical and HHS. The company has 23 employees as of December 31, 2024. Bright Uro operates in a competitive market with competitors including DNC Biotechnology, Clinical Design, Stream DX, COBIO Smart Healthcare Technology and Clariflow, among others.
- Headquarter Aliso Viejo, United States
- Employees 23 as on 31 Dec, 2024
- Founders Derek Herrera
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Bright Uro, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$94.99 M (USD)
in 8 rounds
-
Latest Funding Round
$15 M (USD), Series A
Jun 20, 2025
-
Investors
NIH
& 8 more
-
Employee Count
23
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Bright Uro
Bright Uro has successfully raised a total of $94.99M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $15.0M
-
First Round
First Round
(23 Sep 2021)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Series A - Bright Uro | Valuation |
investors |
|
| Jun, 2025 | Amount | Series A - Bright Uro | Valuation |
investors |
|
| Jan, 2025 | Amount | Grant - Bright Uro | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bright Uro
Bright Uro has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include NIH, Laborie Medical and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Administers health care and support for military personnel and operations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bright Uro
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bright Uro
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bright Uro Comparisons
Competitors of Bright Uro
Bright Uro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNC Biotechnology, Clinical Design, Stream DX, COBIO Smart Healthcare Technology and Clariflow, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
In vitro diagnostic devices for urine infection detection are developed.
|
|
| domain | founded_year | HQ Location |
A patented urine diagnostic device for ten parameters is developed.
|
|
| domain | founded_year | HQ Location |
Uro-flow meters for LUTS diagnosis and patient care are provided.
|
|
| domain | founded_year | HQ Location |
High-throughput clinical analyzers, microscopes, and glucometers are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Provides DIY test kits for benign prostatic hyperplasia (BPH).
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bright Uro
Frequently Asked Questions about Bright Uro
When was Bright Uro founded?
Bright Uro was founded in 2021.
Where is Bright Uro located?
Bright Uro is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.
Who is the current CEO of Bright Uro?
Derek Herrera is the current CEO of Bright Uro. They have also founded this company.
Is Bright Uro a funded company?
Bright Uro is a funded company, having raised a total of $94.99M across 8 funding rounds to date. The company's 1st funding round was a Grant of $1.75M, raised on Sep 23, 2021.
How many employees does Bright Uro have?
As of Dec 31, 2024, the latest employee count at Bright Uro is 23.
What does Bright Uro do?
Bright Uro was founded in 2021 and is headquartered in Aliso Viejo, United States. Operations center on the medical device sector, specifically urology diagnostics. The Glean Urodynamics System is offered, which includes an insertion tool, a Bluetooth-enabled pressure sensor within a flexible silicone tube, a software application, and a uroflowmeter for measuring volume and flow rates. Focus remains on tools for lower urinary tract disease assessment.
Who are the top competitors of Bright Uro?
Bright Uro's top competitors include DNC Biotechnology, Clinical Design and Stream DX.
Who are Bright Uro's investors?
Bright Uro has 9 investors. Key investors include NIH, Laborie Medical, HHS, University of California, and Military Health.